Dexcom, Inc. is a company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management. The Company provides Dexcom Seven that can show a new glucose reading every 5 minutes for up to seven days of uninterrupted wear-time to show where glucose levels are, where they have been and where they are going. The system is made up of three technologies: the sensor, transmitter, and receiver. The sensor is a flexible round wire that goes just under the skin to read glucose levels, and attaches to the skin with an adhesive patch. The transmitter snaps into the sensor; it wirelessly sends glucose information to the Receiver every 5 minutes. The receiver displays glucose levels and trends.

Type
Public
HQ
San Diego, US
Founded
1999
Size (employees)
1,900 (est)
Website
dexcom.com
Dexcom was founded in 1999 and is headquartered in San Diego, US
Report incorrect company information

Key People/Management at Dexcom

Terrance Gregg

Terrance Gregg

Executive Chairman
Kevin Sayer

Kevin Sayer

CEO & President
Andrew Balo

Andrew Balo

EVP, Clinical Affairs, Regulatory Strategies, and Global Access
Rick Doubleday

Rick Doubleday

EVP, Chief Commercial Officer
Jake Leach

Jake Leach

SVP, Research & Development
John Lister

John Lister

GM, Europe, Middle East & Africa
Show more

Dexcom Office Locations

Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr
Show all (1)
Report incorrect company information

Dexcom Financials and Metrics

Dexcom Financials

Dexcom's revenue was reported to be $573.30 m in FY, 2016 which is a 42.6% increase from the previous period.
USD

Revenue (Q3, 2017)

184.6 m

Gross profit (Q3, 2017)

127 m

Gross profit margin (Q3, 2017), %

68.8%

Net income (Q3, 2017)

(2 m)

EBIT (Q3, 2017)

(500 k)

Market capitalization (25-May-2018)

7.8 b

Closing share price (25-May-2018)

88

Cash (30-Sep-2017)

402.1 m
Dexcom's current market capitalization is $7.8 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

160 m259.2 m402 m573.3 m

Revenue growth, %

62%55%43%

Cost of goods sold

59.9 m82.9 m123.6 m194.9 m

Gross profit

100.1 m176.3 m278.4 m378.4 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

42.9 m47.1 m58.8 m69 m72.8 m93.2 m105.2 m116.2 m137.3 m148.6 m142.3 m170.6 m184.6 m

Cost of goods sold

15.3 m17.3 m18.9 m21.8 m26.3 m27.2 m30.5 m41.1 m51.8 m47.5 m48.2 m53.1 m57.6 m

Gross profit

27.6 m29.8 m39.9 m47.2 m46.5 m66 m74.7 m75.1 m85.5 m101.1 m94.1 m117.5 m127 m

Gross profit Margin, %

64%63%68%68%64%71%71%65%62%68%66%69%69%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

43.2 m71.8 m86.1 m94.5 m

Accounts Receivable

26.1 m42.4 m74.1 m101.7 m

Inventories

9 m16 m35.2 m45.4 m

Current Assets

93.1 m145.9 m231.3 m280 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

33.4 m45.7 m49.5 m63.2 m54.2 m67.7 m85.3 m77.9 m87.5 m97.7 m153.5 m395.9 m402.1 m

Accounts Receivable

21.6 m23.8 m28.6 m31.4 m40.2 m45.5 m55.8 m85.9 m101.7 m110.5 m

Inventories

10 m8.9 m11.6 m14.3 m18.4 m22.4 m30.6 m46.1 m42.9 m44.7 m46.5 m42.8 m43.3 m

Current Assets

81.7 m93.6 m105.5 m123.4 m146.2 m170.4 m203.7 m227.4 m241 m258.6 m330.5 m656.8 m692.9 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(29.8 m)(22.4 m)(57.6 m)(65.6 m)

Depreciation and Amortization

7 m8.4 m10.8 m15 m

Inventories

(1.6 m)(7 m)(19 m)(9.8 m)

Cash From Operating Activities

2.4 m23.6 m49 m56.2 m92 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(27.2 m)(12.5 m)(18.5 m)(23.7 m)(12.9 m)(16.6 m)(59.1 m)(19.2 m)(39.4 m)(58.2 m)(41.7 m)(38.8 m)(40.8 m)

Depreciation and Amortization

5.1 m1.9 m3.8 m6 m2.4 m5 m7.7 m3.4 m7.3 m11.4 m3.7 m7.6 m11.9 m

Inventories

(2.5 m)200 k(2.6 m)(5.3 m)(2.4 m)(6.4 m)(14.6 m)(10.9 m)(7.2 m)(8.9 m)(1 m)2.8 m2.2 m

Cash From Operating Activities

(2 m)(2.4 m)3.8 m15.2 m3.4 m19.8 m37.7 m(200 k)19.9 m42.9 m300 k14.6 m50.8 m
USDY, 2017

Revenue/Employee

97.2 k

Financial Leverage

2.2 x
Show all financial metrics

Dexcom Operating Metrics

FY, 2016

Patents (foreign)

48

Patents Pending

417

Trademarks (US)

24

Trademarks (foreign)

54
Show all operating metrics
Report incorrect company information

Dexcom News and Updates

Blood Glucose Meter Market Business Outlook and Key Manufacturers Report 2018

This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies Posted via Industry Today. Follow us on Twitter @IndustryToday

Worldwide Artificial Pancreas Market Multiply Relentlessly; Asserts MRFR Unleashing Industry Forecast - 2023

Market research future has a half cooked research report on global Artificial Pancreas market. The global Artificial Pancreas market is growing rapidly by 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

POC Blood Glucose Monitoring Devices Market 2017 Global Manufactures : Cercacor, OrSense, Dexcom and Terumo

Market Research Store added a depth and professional market study report on Global POC Blood Glucose Monitoring Devices Market 2017. This report also provides more details about Market Size, Share, Analysis, import/export consumption, supply and demand Figures, cost, price, revenue and gross margins…

Global Diabetes Care Devices Market sales is growing at 5.9% CAGR till 2022

Global diabetic care device market expected to reach USD 26.00 billion by 2021, growing at a CAGR of 5.9% between 2016 and 2021. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information